Overseas deal rules end one combo, alter another

Published



New government rules aimed at curbing overseas deals that cut corporate taxes appear to be working, just not entirely the way regulators intended.

Salix Pharmaceuticals Ltd., based in Raleigh, N.C., said Friday it will scrap a planned merger with the subsidiary of an Italian drugmaker due to a changed “political environment” that creates uncertainty about the deal’s benefits.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.